Last year, ICU Medical Inc generated 1.11B USD for its biggest-performing segment, Infusion Consumables. The United States made the largest contribution, accounting for 1.36B USD last year. For the latest quarter, ICU Medical Inc reported the revenue of 289.28M USD for the period ending 2026-06-30, which came from the top-performing segment, Infusion Consumables. United States contributed the highest revenue, at 349.90M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Infusion Consumables

Consumables

Infusion Systems

Vital Care

IV Solutions

Critical Care

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Infusion Consumables

1.11B(33.20%)

1.04B(30.37%)

969.13M(30.02%)

--(--)

555.19M(42.18%)

473.74M(37.27%)

477.61M(37.72%)

Consumables

1.11B(33.20%)

1.04B(30.37%)

969.13M(30.02%)

974.99M(42.76%)

--(--)

Infusion Systems

684.21M(20.48%)

652.41M(19.07%)

629.04M(19.49%)

617.43M(27.08%)

352.32M(26.77%)

359.69M(28.30%)

328.28M(25.93%)

Vital Care

437.92M(13.11%)

690.77M(20.19%)

660.95M(20.47%)

687.57M(30.16%)

--(--)

IV Solutions

--(--)

359.48M(27.31%)

388.97M(30.60%)

414.97M(32.77%)

Critical Care

--(--)

49.32M(3.75%)

48.60M(3.82%)

45.34M(3.58%)

Other

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

EMEA

APAC

Others

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

1.36B(60.78%)

1.53B(64.32%)

1.44B(63.74%)

1.46B(64.04%)

941.81M(71.55%)

910.63M(71.65%)

923.34M(72.92%)

EMEA

411.68M(18.45%)

393.53M(16.52%)

373.57M(16.54%)

367.41M(16.11%)

147.49M(11.20%)

132.76M(10.45%)

130.53M(10.31%)

APAC

232.90M(10.44%)

232.82M(9.77%)

241.70M(10.70%)

257.21M(11.28%)

85.69M(6.51%)

79.61M(6.26%)

--(--)

Others

230.56M(10.33%)

223.59M(9.39%)

203.84M(9.02%)

195.31M(8.57%)

141.32M(10.74%)

148.00M(11.64%)

212.34M(16.77%)